Content Navigation
( All
None )
Target General Information |
Top |
Target ID |
T70067 |
Target Info
|
Target Name |
TRAIL receptor 2 (TRAIL-R2) |
Synonyms |
ZTNFR9; UNQ160/PRO186; Tumor necrosis factor receptor superfamily member 10B; TRICK2; TRAILR2; TNF-related apoptosis-inducing ligand receptor 2; KILLER; Death receptor 5; DR5; CD262 |
Target Type |
Clinical trial Target |
Gene Name |
TNFRSF10B |
Biochemical Class |
Cytokine receptor |
UniProt ID |
|
Targeted Antigens of CAR-T Cell Therapy |
Top |
CAR T-Cell Therapy Drug(s) |
Anti-DR5 cells |
Drug Info
|
Phase 1/2 |
Hepatocellular carcinoma |
[1] |
References |
Top |
REF 1 |
ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.